Company Aimmune Therapeutics, Inc.
Equities
AIMT
US00900T1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | 57 | 01/20/01 | |
Jim Pepin
LAW | General Counsel | - | - |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,450,142 | 50,930,993 ( 77.82 %) | 0 | 77.82 % |
Company contact information
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.comSector
1st Jan change | Capi. | |
---|---|---|
-1.32% | 103B | |
+8.51% | 101B | |
+4.40% | 23.07B | |
-12.06% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.39% | 16.94B | |
+6.50% | 14.07B | |
+38.53% | 12.35B |